It takes too long and costs too much to bring new drugs to market. So let's beef up efforts to screen existing drugs for new uses, argue Curtis R. Chong and David J. Sullivan Jr.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
DiMasi, J. A., Hansen, R. W. & Grabowski, H. G. J. Health Econ. 22, 151–185 (2003).
Cohen, F. J. Nature Rev. Drug Discov. 4, 78–84 (2005).
Ashburn, T. T. & Thor, K. B. Nature Rev. Drug Discov. 3, 673–683 (2004).
Rothstein, J. D. et al. Nature 433, 73–77 (2005).
Moran, M. PLoS Med. 2, e302 (2005).
Sundar, S. et al. N. Engl. J. Med. 347, 1739–1746 (2002).
Chong, C. R. et al. Nature Chem. Biol. 2, 415–416 (2006).
Lipinski, C. A. et al. Adv. Drug Deliv. Rev. 46, 3–26 (2001).
Sussman, G. L. et al. J. Allergy Clin. Immunol. 104, 100–106 (1999).
Weber, W. W. Mol. Diagn. 4, 299–307 (1999).
Voigt, J. H. et al. J. Chem. Inf. Comput. Sci. 41, 702–712 (2001).
Wishart, D. S. et al. Nucleic Acids Res. 34, D668–D672 (2006).
Acknowledgements
We thank Walter Pudelko for invaluable help with Supplementary Table 2.
Author information
Authors and Affiliations
Supplementary information
Supplementary Table 1
(DOC 100 kb)
Supplementary Table 2
(XLS 818 kb)
Rights and permissions
About this article
Cite this article
Chong, C., Sullivan, D. New uses for old drugs. Nature 448, 645–646 (2007). https://doi.org/10.1038/448645a
Published:
Issue Date:
DOI: https://doi.org/10.1038/448645a